With two full phases of clinical trial data already completed, the results speak for themselves record-setting weight loss, dramatic improvements in metabolic markers, and promising impacts on overall healthspan
Compounded GLP-1 medications may be prescribed by a range of independent licensed healthcare professionals, including nurse practitioners, general practitioners, endocrinologists, family medicine physicians, and diabetes management specialists, among others
Observational studies have produced mixed results regarding the impact of GLP-1RAs on intestinal obstruction in patients with T2DM
How long does an IV session take
in 2025, Scientific American reported an average weight loss of 15% for participants on Semaglutide, far exceeding that achieved with most behavioral interventions alone